JAK 1 and 2 inhibitor superior to adalimumab in treatment of rheumatoid arthritis: The RA-BEAM trial
1. Baricitinib, an oral, once-daily inhibitor of JAK1 and JAK2, has shown promise in the treatment of rheumatoid arthritis (RA). ...
Tag: rheumatoid arthritis
Non-TNF-targeted therapies more effective than anti-TNF agents in uncontrolled rheumatoid arthritis
1. The addition of a non-TNF-targeted biologic therapy is superior to the addition of an anti-TNF biologic therapy in patients ...
Recent intestinal, urological infections linked with lower rheumatoid arthritis risk
1. Patients who developed rheumatoid arthritis (RA) were less likely to have had a gastrointestinal (GI) or genitourinary (GU) infection ...
Patient Basics: Rheumatoid Arthritis
Originally published by Harvard Health. What Is It? Rheumatoid arthritis is a chronic (long-lasting) inflammatory disease that causes pain, stiffness, warmth, ...
Tofacitinib superior to methotrexate monotherapy for rheumatoid arthritis
1. At 6 months, patients receiving tofacitinib monotherapy had reduced structural joint damage compared to methotrexate monotherapy. 2. Patients treated ...
Combination therapy with tofacitinib improves response in rheumatoid arthritis
Image: PD 1. Patients with rheumatoid arthritis (RA) taking tofacitinib in combination with non-biologic disease-modifying antirheumatic drugs (DMARDs) demonstrated an ...
2 Minute Medicine Rewind July 22 – July 28, 2013
Image: PD In this section, we will highlight the key high-impact studies, updates, and analyses published in medicine during the ...
[BMJ] Elevated rheumatoid factor associated with 26x risk of developing rheumatoid arthritis
Image: CC/James Heilman Primer: Rheumatoid factors (RF) are autoantibodies directed against the Fc portion of immunoglobulin. Serum IgM RF occurs ...